Literature DB >> 28805147

A comparison of transdermal over-the-counter lidocaine 3.6% menthol 1.25%, Rx lidocaine 5% and placebo for back pain and arthritis.

Eric Castro1, David Dent2.   

Abstract

AIM: Transdermal lidocaine therapy has become a gold standard as part of a treatment regimen for patients who suffer from localized pain. We compared transdermal patches: over-the-counter (OTC) lidocaine 3.6% combined with menthol 1.25%, prescription lidocaine 5% (Rx) and placebo.
METHODS: In a double-blind, placebo-controlled trial, 87 patients were randomized to: OTC, Rx or placebo.
RESULTS: OTC met primary end points of noninferiority compared with Rx for efficacy, side effects and quality of life. Versus placebo, OTC proved superiority for efficacy, general activity and normal work. Side effects were similar.
CONCLUSION: It is theorized that menthol's ability to increase skin permeability facilitated more efficient drug delivery to the site of pain causing higher than expected efficacy. Decreased cost and resource utilization could benefit patients and payers.

Entities:  

Keywords:  arthritis; back pain; lidocaine; local anesthetic; osteoarthritis; patch; transdermal

Mesh:

Substances:

Year:  2017        PMID: 28805147     DOI: 10.2217/pmt-2017-0029

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  3 in total

1.  Pain management in the emergency department: a clinical review.

Authors:  Sergey M Motov; Katherine Vlasica; Igor Middlebrook; Alexis LaPietra
Journal:  Clin Exp Emerg Med       Date:  2021-12-31

Review 2.  Topical Lidocaine for Chronic Pain Treatment.

Authors:  Marion Voute; Véronique Morel; Gisèle Pickering
Journal:  Drug Des Devel Ther       Date:  2021-09-29       Impact factor: 4.162

3.  Efficacy of transdermal 4% lidocaine patches for postoperative pain management after arthroscopic rotator cuff repair: a prospective trial.

Authors:  Donghoon Lee; Richard E Campbell; Morgan L Leider; Matthew M Pepe; Bradford S Tucker; Fotios P Tjoumakaris
Journal:  JSES Int       Date:  2021-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.